Ben Cousins arrested for drug possession and refusing drug test. Will become the biggest story in Australian sporting history
Xtc used and found on Primary school students for the first time
John Fay, the Australian who ran the Sydney Olympics becomes the head of the World Anti-doping Body
Harrington Group
Mike Fitzpatric HGR's largest share holder is Chairman of the AFL
Mr. Peter King: Non-Executive Chairman Mr. King has a long and distinguished professional and public career. He is a Rhodes Scholar and a practicing barrister specializing primarily in commercial and public law at Queen's Square Chambers Sydney, Australia. Formerly he was a Federal Member of Parliament and local mayor, chair of a successful political organization, and of a major division of UNESCO in Paris. Mr. King has also had a particular interest and long standing association with defense issues. He retired as Lieutenant Commander in the Royal Australian Navy, was an officer in the Naval Reserves, and as a Member of Parliament he took a special interest in Defense and Police issues, and was patron of a major returned soldiers organization. Mr. King's government, legal and defense experience and contacts will help to guide and govern the company.
Mr. Brian Andrews: Managing Director Mr. Andrews has twenty years experience in the medical devices market where he successfully commercialised a broad range of technologies ranging from invitro diagnostics to high tech medical optical devices used for minimally invasive surgery. Among the highlights of his successful career Mr. Andrews has lived and worked in the United States and United Kingdom where he has lead multidisciplinary teams in the development and commercialisation of market leading brands. He has managed both the internal development and commercialisation of new technologies and brands along with complex high value strategic alliances. He has a bachelor of science, a bachelor of business majoring in marketing and an MBA from Monash University.
Mr. Andrew Paice: Chief Financial Officer Mr. Paice has worked in a variety of senior finance roles across a broad spectrum of industries. Mr. Paice has lived and worked internationally and in Turkey managed the regional financial affairs of a global pharmaceutical organisation. Mr. Paice also played a lead role in developing and implementing a shared services infrastructure for global pharmaceutical giant Bristol-Myers Squibb delivering to the organisation substantial operations savings through the alignment of critical resources and infrastructure across all operating divisions. Mr. Paice has a bachelor of business majoring in accounting from Swinburne University.
There is nothing more to add or say about the prospects of HGR. I will check the share price in a one year so until then good-luck all.
HGR Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
